PhRMA, a lobbying group for pharmaceutical companies, called the proposal “price controls” and said it was “disappointed the administration put the needs of patients aside with these proposals.” There will likely be escalating pushback from the industry against the new proposal intended to curb high drug prices.

from Kaiser Health News https://ift.tt/2z364PZ

Related Posts:

0 comments:

Post a Comment

Popular Posts